CHI3L1 and myeloid sarcoma: An increase of YKL-40 in the brain and/or cerebrospinal fluid (CSF) is associated with a variety of immune and inflammatory diseases, particularly neurological and neurodegenerative diseases with an inflammatory component, such as multiple sclerosis (MS), Alzheimer's disease (AD), and stroke (10–12).